Azaspiromycin and pentalenolactone derivatives with insecticidal activities against Plutella xylostella from Streptomyces huasconensis NA10
Pest Management Science · 2026
DOI: 10.1002/ps.70751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pest Management Science, 2026. Verfasst von Yan Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Forest Ecology and Silviculture, Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China. Hauptthemen laut MEDLINE: Insecticides, Moths, Streptomyces, Spiro Compounds. Die Arbeit nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Plutella xylostella larvae constitute the most destructive pest of cruciferous crops globally and have caused huge economic losses. However, chemical pesticides for their control are toxic to the ecological environment and there is pest resistance against them. Searching for compounds with insecticidal activity that are environmentally friendly has become imperative. RESULTS Crude extracts of Streptomyces huasconensis NA10 showed significant insecticidal activities against P . xylostella larvae, and genomic mining was used to predict that this bacterial strain could produce potentially undescribed insecticidal compounds. To discover new natural biopesticides, three new compounds, azaspiromycin, pentalenolactone J and neopentalenolactone G, along with one known compound, pentalenolactone O, were isolated from marine‐derived S. huasconensis NA10, guided by insecticidal activity screening. Their structures were identified through comprehensive spectroscopic data analysis and quantum chemical calculations. Remarkably, azaspiromycin contains a unique spiro‐tetrahydropyran‐ γ ‐lactam bicyclic skeleton, previously unreported in natural products. Furthermore, plausible biosynthetic pathways of four compounds were deduced. In the insecticidal activity assay, these compounds showed moderate‐to‐strong insecticidal effects [median lethal dose (LD 50 ) = 5.1–25.5 μ m ]. Among them, azaspiromycin and pentalenolactone O demonstrated significant insecticidal effects (LD 50 = 8.3 and 5.1 μ m ), comparable to the positive control abamectin (LD 50 = 4.2 μ m ). The result of acute toxicity further indicated that these compounds were safe for a nontarget organism (silkworm). This is the first report on the insecticidal efficacy of azaspiromycin and pentalenolactone derivatives against P . xylostella larvae. CONCLUSION This study demonstrates the potential of azaspiromycin and pentalenolactone derivatives as novel biopesticides for effective P . xylostella control. © 2026 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Forest Ecology and Silviculture, Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China.
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.
- College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
ORCID-Profile: Huaqi Pan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Bai, Y., Tan, M., Sun, H., Wang, X., Song, X., Hu, J., & Pan, H. (2026). Azaspiromycin and pentalenolactone derivatives with insecticidal activities against Plutella xylostella from Streptomyces huasconensis NA10. Pest Management Science. https://doi.org/10.1002/ps.70751
Vancouver
Bai Y, Tan M, Sun H, Wang X, Song X, Hu J, et al. Azaspiromycin and pentalenolactone derivatives with insecticidal activities against Plutella xylostella from Streptomyces huasconensis NA10. Pest Management Science. 2026. doi:10.1002/ps.70751
BibTeX
@article{Bai2026,
author = {Bai, Yan and Tan, Meiyan and Sun, Hailiang and Wang, Xiaoke and Song, Xiaoyu and Hu, Jiangchun and Pan, Huaqi},
title = {Azaspiromycin and pentalenolactone derivatives with insecticidal activities against Plutella xylostella from Streptomyces huasconensis NA10},
journal = {Pest Management Science},
year = {2026},
doi = {10.1002/ps.70751}
}
EUVIMED